Building Resilience in Cell Therapy Supply Chains: Ensuring Timely and Safe Delivery
Executive Summary In the fast-paced world of cell and gene therapies, building a resilient...
read Details
C> is vulnerable to violent shock during transportation.
C> is vulnerable to violent shock during transportation.
Modality Solutions is paving the way for the future of pharmaceutical transportation testing.
The global cold chain requires non-standard modes of transportation like speedboats, helicopters, drones, and more. Lack of infrastructure shouldn’t stop therapies from getting where they need to go. Real-world shipping tests aren’t effective for measuring viability, which is why Modality Solutions’ Advantage Transport Simulation Laboratory™ conducts worst-case scenarios.
Stay on top of the industry trends
You may also like
A New Class of Therapy: Monoclonal Antibody Fragments
Monoclonal Antibodies: Monoclonal antibodies (mAbs) are clones of the antibodies that our body secretes...
read Details
Non-Standard Modes of Transportation for Cell & Gene Therapies | Executive Insights with Carson Dickey
Recently, while attending the Allogenic Cell Therapy Summit in Boston, MA, Carson was at...
read Details